semaglutide depot / Mapi Pharma - LARVOL DELTA

Semaglutide Depot, a Long-Acting Injection of Semaglutide Administered Once Every Four Weeks—Pharmacokinetic Modeling and Human-Based Allometric Scaling (ADA 2025) - "Based on the pre-clinical results Semaglutide Depot given once every 28 days in doses of 4 to 8 mg is expected to reach the target human PK profile while offering an improved safety profile. Phase I/II clinical study is planned to explore Semaglutide Depot PK, safety and efficacy in humans including these dose ranges."

PK/PD data • Metabolic Disorders